Compare
Greenlane Holdings, Inc. vs Bio Green Med Solution, Inc. vs Core & Main, Inc.
| Latest fiscal year | Greenlane Holdings, Inc. GNLN | Bio Green Med Solution, Inc. BGMS | Core & Main, Inc. CNM |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-02-01 |
| Revenue | $4.36M | $747.0K | $7.65B |
| Revenue growth (YoY) | -67.2% | n/m | +2.8% |
| Gross margin | -286.2% | n/a | 26.9% |
| Operating margin | n/m | n/m | 9.4% |
| Net margin | n/m | -401.3% | 5.8% |
| Net income | -$85.58M | -$3.00M | $441.00M |
| EPS (Diluted) | -$11.42 | -$6.45 | $2.31 |
| Operating cash flow | -$16.26M | -$4.77M | $650.00M |
| Free cash flow | -$16.36M | n/a | $604.00M |
| Cash & equivalents | $32.51M | $3.50M | $220.00M |
| Total assets | $74.93M | $8.19M | $6.08B |
| Total liabilities | $7.21M | $1.34M | $4.01B |
| Shareholders' equity | $67.87M | $6.84M | $2.00B |
| Return on year-end equity | -126.1% | -43.8% | 22.1% |
| Shares outstanding | n/a | 5.40M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Greenlane Holdings, Inc. | Bio Green Med Solution, Inc. | Core & Main, Inc. |
|---|---|---|---|
| Latest | $4.36M Ended 2025-12-31 | $747.0K Ended 2025-12-31 | $7.65B Ended 2026-02-01 |
| 1 year earlier | $13.28M Ended 2024-12-31 | $43.0K Ended 2024-12-31 | $7.44B Ended 2025-02-02 |
| 2 years earlier | $65.37M Ended 2023-12-31 | $420.0K Ended 2023-12-31 | $6.70B Ended 2024-01-28 |
| 3 years earlier | $137.09M Ended 2022-12-31 | $0 Ended 2022-12-31 | $6.65B Ended 2023-01-29 |
| 4 years earlier | $166.06M Ended 2021-12-31 | $0 Ended 2021-12-31 | $5.00B Ended 2022-01-30 |